IBDEI2MD ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1626,0)
 ;;=IMMUNIZATION^3^127
 ;;^UTILITY(U,$J,358.4,1627,0)
 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^127
 ;;^UTILITY(U,$J,358.4,1628,0)
 ;;=COUNSELING RISK FACTOR REDUCTION^2^127
 ;;^UTILITY(U,$J,358.4,1629,0)
 ;;=OTH PREVENTIVE MEDICINE SERVICES^4^127
 ;;^UTILITY(U,$J,358.4,1630,0)
 ;;=PREVENTIVE MEDICINE,GROUP^7^127
 ;;^UTILITY(U,$J,358.4,1631,0)
 ;;=PREVENTIVE HEALTH VISIT-EST PT^5^127
 ;;^UTILITY(U,$J,358.4,1632,0)
 ;;=PREVENTIVE HEALTH VISIT-NEW PT^6^127
 ;;^UTILITY(U,$J,358.4,1633,0)
 ;;=BODY  MASS INDEX (BMI)^2^128
 ;;^UTILITY(U,$J,358.4,1634,0)
 ;;=COUNSELING^3^128
 ;;^UTILITY(U,$J,358.4,1635,0)
 ;;=PREVENTIVE HEALTH ENCOUNTER^1^128
 ;;^UTILITY(U,$J,358.4,1636,0)
 ;;=HISTORY OF ILLNESS^4^128
 ;;^UTILITY(U,$J,358.4,1637,0)
 ;;=LONG TERM DRUG USE^5^128
 ;;^UTILITY(U,$J,358.4,1638,0)
 ;;=OTHER^10^128
 ;;^UTILITY(U,$J,358.4,1639,0)
 ;;=SCREENING^6^128
 ;;^UTILITY(U,$J,358.4,1640,0)
 ;;=TRANSPLANT^7^128
 ;;^UTILITY(U,$J,358.4,1641,0)
 ;;=VACCINATIONS^8^128
 ;;^UTILITY(U,$J,358.4,1642,0)
 ;;=WOMEN'S HEALTH^9^128
 ;;^UTILITY(U,$J,358.4,1643,0)
 ;;=NEW PATIENT^2^129
 ;;^UTILITY(U,$J,358.4,1644,0)
 ;;=ESTABLISHED PATIENT^1^129
 ;;^UTILITY(U,$J,358.4,1645,0)
 ;;=CONSULTATIONS^3^129
 ;;^UTILITY(U,$J,358.4,1646,0)
 ;;=IMMUNIZATION^7^130
 ;;^UTILITY(U,$J,358.4,1647,0)
 ;;=INJECTION^8^130
 ;;^UTILITY(U,$J,358.4,1648,0)
 ;;=SKIN TEST^17^130
 ;;^UTILITY(U,$J,358.4,1649,0)
 ;;=NURSING PROCEDURES^10^130
 ;;^UTILITY(U,$J,358.4,1650,0)
 ;;=MINOR PROCEDURES^9^130
 ;;^UTILITY(U,$J,358.4,1651,0)
 ;;=SPLINTS^18^130
 ;;^UTILITY(U,$J,358.4,1652,0)
 ;;=EDUCATION/TRAINING^3^130
 ;;^UTILITY(U,$J,358.4,1653,0)
 ;;=ALLERGY SHOTS^1^130
 ;;^UTILITY(U,$J,358.4,1654,0)
 ;;=EKG^4^130
 ;;^UTILITY(U,$J,358.4,1655,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^2^130
 ;;^UTILITY(U,$J,358.4,1656,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^11^130
 ;;^UTILITY(U,$J,358.4,1657,0)
 ;;=GYN PROCEDURES^5^130
 ;;^UTILITY(U,$J,358.4,1658,0)
 ;;=PREVENTIVE MED-EST PT^13^130
 ;;^UTILITY(U,$J,358.4,1659,0)
 ;;=PREVENTIVE MED-NEW PT^14^130
 ;;^UTILITY(U,$J,358.4,1660,0)
 ;;=RISK FACTOR REDUCTION^16^130
 ;;^UTILITY(U,$J,358.4,1661,0)
 ;;=PREVENTIVE GROUP COUNSELING^12^130
 ;;^UTILITY(U,$J,358.4,1662,0)
 ;;=PROLONGED SERVICE^15^130
 ;;^UTILITY(U,$J,358.4,1663,0)
 ;;=IMMUNIZATION ADMINISTRATION^6^130
 ;;^UTILITY(U,$J,358.4,1664,0)
 ;;=PC COMMON DIAGNOSES^1^131
 ;;^UTILITY(U,$J,358.4,1665,0)
 ;;=ADMINISTRATIVE TOPICS^2^131
 ;;^UTILITY(U,$J,358.4,1666,0)
 ;;=ANGINA^3^131
 ;;^UTILITY(U,$J,358.4,1667,0)
 ;;=ATHEROSCLEROSIS^4^131
 ;;^UTILITY(U,$J,358.4,1668,0)
 ;;=CARDIOVASCULAR^5^131
 ;;^UTILITY(U,$J,358.4,1669,0)
 ;;=DERMATOLOGY^9^131
 ;;^UTILITY(U,$J,358.4,1670,0)
 ;;=EAR DISORDERS^10^131
 ;;^UTILITY(U,$J,358.4,1671,0)
 ;;=EENT^11^131
 ;;^UTILITY(U,$J,358.4,1672,0)
 ;;=ENDOCRINE/METABOLIC^12^131
 ;;^UTILITY(U,$J,358.4,1673,0)
 ;;=EYE DISORDERS^13^131
 ;;^UTILITY(U,$J,358.4,1674,0)
 ;;=EYE INJURY^14^131
 ;;^UTILITY(U,$J,358.4,1675,0)
 ;;=GASTROENTEROLOGY^15^131
 ;;^UTILITY(U,$J,358.4,1676,0)
 ;;=GU/RENAL^16^131
 ;;^UTILITY(U,$J,358.4,1677,0)
 ;;=HEADACHE^17^131
 ;;^UTILITY(U,$J,358.4,1678,0)
 ;;=HEART FAILURE^18^131
 ;;^UTILITY(U,$J,358.4,1679,0)
 ;;=HEART VALVE DISEASE^19^131
 ;;^UTILITY(U,$J,358.4,1680,0)
 ;;=HEMATOLOGY/ONCOLOGY^20^131
 ;;^UTILITY(U,$J,358.4,1681,0)
 ;;=HISTORY OF ILLNESS^21^131
 ;;^UTILITY(U,$J,358.4,1682,0)
 ;;=INFECTIOUS DISEASE^22^131
 ;;^UTILITY(U,$J,358.4,1683,0)
 ;;=LIVER DISEASE^23^131
 ;;^UTILITY(U,$J,358.4,1684,0)
 ;;=MENTAL HEALTH^25^131
 ;;^UTILITY(U,$J,358.4,1685,0)
 ;;=MOVEMENT DISORDERS^26^131
 ;;^UTILITY(U,$J,358.4,1686,0)
 ;;=MUSCULOSKELETAL^27^131
